The objective of DG INFSO when calling its stakeholders to contribute to this consultation is to raise awareness on the importance of ICT solutions in a future regulatory framework for pharmaceuticals, particularly in the area of safety of medicines
The Commission intends to improve the regulatory, non-regulatory and RTD framework for pharmaceuticals. For example, specific initiatives in the field of pharmacovigilance and variations have already been announced.
Contribution from all stakeholders -Patients organisations, Member States authorities, international bodies, industry associations and individual companies -innovative, generic and self-medication sectors-, healthcare professionals, or any other person or legal entity interested in this field- are welcome.
Stakeholders who are not established within the EU are equally invited to comment.
Comments from Small and Medium-sized Enterprises (SMEs) involved in the pharmaceutical sector are especially welcomed.
Contributions should preferably not exceed 5 pages.
Deadline to contribute: 12 October 2007